Page 125 - 2020_07-Haematologica-web

Transforming activities of the NUP98-KMT2A fusion
gene products involved in 11q23 transloca- tion and possible mechanisms of leukemo- genesis by MLL truncation. Oncogene. 1996;13(9):1945-1953.
22. Iacovino M, Hernandez C, Xu Z, Bajwa G, Prather M, Kyba M. A conserved role for Hox paralog group 4 in regulation of hematopoietic progenitors. Stem Cells Dev. 2009;18(5):783-792.
23. Stavropoulou V, Kaspar S, Brault L, et al. MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML express- ing EMT-related genes linked to poor out- come. Cancer Cell. 2016;30(1):43-58.
24. Thanasopoulou A, Tzankov A, Schwaller J. Potent co-operation between the NUP98- NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction. Haematologica. 2014;99(9):1465-1471.
25. Franks TM, McCloskey A, Shokirev MN, Benner C, Rathore A, Hetzer MW. Nup98 recruits the Wdr82-Set1A/COMPASS com- plex to promoters to regulate H3K4 trimethylation in hematopoietic progenitor cells. Genes Dev. 2017;31(22):2222-2234.
26. Zuber J, Shi J, Wang E, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011;478(7370):524-528.
27. Stavropoulou V, Almosailleakh M, Royo H, et al. A novel inducible mouse model of MLL-ENL-driven mixed-lineage acute leukemia. HemaSphere. 2018;2(4):e51.
28. Milne TA. Mouse models of MLL leukemia: recapitulating the human disease. Blood. 2017;129(16):2217-2223.
29. Fisher JN, Stavropoulou V, Kalleda N, Schwaller J. The impact of the cellular origin in acute myeloid leukemia: learning from mouse models. Hemasphere. 2019;3(1): e152.
30. Lin YW, Slape C, Zhang Z, Aplan PD.
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood. 2005;106(1):287-295.
31. Slape C, Liu LY, Beachy S, Aplan PD. Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompa- nied by spontaneous mutations in Nras, Kras, and Cbl. Blood. 2008;112(5):2017- 2019.
32. Pineault N, Buske C, Feuring-Buske M, et al. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. Blood. 2003;101(11):4529-4538.
33. Slape C, Hartung H, Lin YW, Bies J, Wolff L, Aplan PD. Retroviral insertional mutage- nesis identifies genes that collaborate with NUP98-HOXD13 during leukemic trans- formation. Cancer Res. 2007;67(11):5148- 5155.
34. Humeniuk R, Koller R, Bies J, Aplan P, Wolff L. Brief report: loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice. Stem Cells. 2014;32(5):1361-1366.
35. Imren S, Heuser M, Gasparetto M, et al. Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13. Blood. 2014;124(24):3608- 3612.
36. Greenblatt S, Li L, Slape C, et al. Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model. Blood. 2012;119(12):2883-2894.
37. Liu H, Cheng EH, Hsieh JJ. Bimodal degra- dation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regula- tory circuit lost in leukemogenic MLL fusions. Genes Dev. 2007;21(19):2385-2398.
38. Liu H, Takeda S, Kumar R, et al.
Phosphorylation of MLL by ATR is required for execution of mammalian S-phase check- point. Nature. 2010;467(7313):343-346.
39. Chua KF, Mostoslavsky R, Lombard DB, et al. Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab. 2005;2(1):67-76.
40. Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO tran- scription factors by the SIRT1 deacetylase. Science. 2004;303(5666):2011-2015.
41. Tran D, Bergholz J, Zhang H, et al. Insulin- like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging Cell. 2014;13(4):669-678.
42. Duan L, Maki CG. The IGF-1R/AKT path- way determines cell fate in response to p53. Transl Cancer Res. 2016;5(6):664-675.
43. Park AM, Tsunoda I, Yoshie O. Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130. J Biol Chem. 2018;293(41):15815-15826.
44. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266(5193):2011-2015.
45. Cesare AJ, Reddel RR. Alternative lengthen- ing of telomeres: models, mechanisms and implications. Nat Rev Genet. 2010;11 (5):319-330.
46. Katakura Y, Udono M, Katsuki K, et al. Protein kinase C delta plays a key role in cel- lular senescence programs of human normal diploid cells. J Biochem. 2009;146(1):87-93.
47. Shi A, Murai MJ, He S, et al. Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia. Blood. 2012;120(23):4461-4469.
48. Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature. 2010;468(7327):1067-1073.
haematologica | 2020; 105(7)
1867